228 related articles for article (PubMed ID: 34004189)
1. Should Vitamin A Injections to Prevent Bronchopulmonary Dysplasia or Death Be Reserved for High-Risk Infants? Reanalysis of the National Institute of Child Health and Human Development Neonatal Research Network Randomized Trial.
Rysavy MA; Li L; Tyson JE; Jensen EA; Das A; Ambalavanan N; Laughon MM; Greenberg RG; Patel RM; Pedroza C; Bell EF;
J Pediatr; 2021 Sep; 236():78-85.e5. PubMed ID: 34004189
[TBL] [Abstract][Full Text] [Related]
2. Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates.
Shah SS; Ohlsson A; Halliday HL; Shah VS
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002058. PubMed ID: 29041034
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of Treatment Effects of Hydrocortisone by Risk of Bronchopulmonary Dysplasia or Death Among Extremely Preterm Infants in the National Institute of Child Health and Human Development Neonatal Research Network Trial: A Secondary Analysis of a Randomized Clinical Trial.
Gentle SJ; Rysavy MA; Li L; Laughon MM; Patel RM; Jensen EA; Hintz S; Ambalavanan N; Carlo WA; Watterberg K;
JAMA Netw Open; 2023 May; 6(5):e2315315. PubMed ID: 37256621
[TBL] [Abstract][Full Text] [Related]
4. Early postnatal high-dose fat-soluble enteral vitamin A supplementation for moderate or severe bronchopulmonary dysplasia or death in extremely low birthweight infants (NeoVitaA): a multicentre, randomised, parallel-group, double-blind, placebo-controlled, investigator-initiated phase 3 trial.
Meyer S; Bay J; Franz AR; Ehrhardt H; Klein L; Petzinger J; Binder C; Kirschenhofer S; Stein A; Hüning B; Heep A; Cloppenburg E; Muyimbwa J; Ott T; Sandkötter J; Teig N; Wiegand S; Schroth M; Kick A; Wurm D; Gebauer C; Linnemann K; Kittel J; Wieg C; Kiechl-Kohlendorfer U; Schmidt S; Böttger R; Thomas W; Brevis Nunez F; Stockmann A; Kriebel T; Müller A; Klotz D; Morhart P; Nohr D; Biesalski HK; Giannopoulou EZ; Hilt S; Poryo M; Wagenpfeil S; Haiden N; Ruckes C; Ehrlich A; Gortner L;
Lancet Respir Med; 2024 Jul; 12(7):544-555. PubMed ID: 38643780
[TBL] [Abstract][Full Text] [Related]
5. Enteral vitamin A for reducing severity of bronchopulmonary dysplasia in extremely preterm infants: a randomised controlled trial.
Rakshasbhuvankar A; Patole S; Simmer K; Pillow JJ
BMC Pediatr; 2017 Dec; 17(1):204. PubMed ID: 29246130
[TBL] [Abstract][Full Text] [Related]
6. Effect of Hydrocortisone Therapy Initiated 7 to 14 Days After Birth on Mortality or Bronchopulmonary Dysplasia Among Very Preterm Infants Receiving Mechanical Ventilation: A Randomized Clinical Trial.
Onland W; Cools F; Kroon A; Rademaker K; Merkus MP; Dijk PH; van Straaten HL; Te Pas AB; Mohns T; Bruneel E; van Heijst AF; Kramer BW; Debeer A; Zonnenberg I; Marechal Y; Blom H; Plaskie K; Offringa M; van Kaam AH;
JAMA; 2019 Jan; 321(4):354-363. PubMed ID: 30694322
[TBL] [Abstract][Full Text] [Related]
7. Vitamin A supplementation for prevention of bronchopulmonary dysplasia in very-low-birth-weight premature Thai infants: a randomized trial.
Kiatchoosakun P; Jirapradittha J; Panthongviriyakul MC; Khampitak T; Yongvanit P; Boonsiri P
J Med Assoc Thai; 2014 Oct; 97 Suppl 10():S82-8. PubMed ID: 25816542
[TBL] [Abstract][Full Text] [Related]
8. Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort.
Lapcharoensap W; Gage SC; Kan P; Profit J; Shaw GM; Gould JB; Stevenson DK; O'Brodovich H; Lee HC
JAMA Pediatr; 2015 Feb; 169(2):e143676. PubMed ID: 25642906
[TBL] [Abstract][Full Text] [Related]
9. Early postnatal additional high-dose oral vitamin A supplementation versus placebo for 28 days for preventing bronchopulmonary dysplasia or death in extremely low birth weight infants.
Meyer S; Gortner L;
Neonatology; 2014; 105(3):182-8. PubMed ID: 24434948
[TBL] [Abstract][Full Text] [Related]
10. Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants.
Shah SS; Ohlsson A; Halliday HL; Shah VS
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002057. PubMed ID: 29035425
[TBL] [Abstract][Full Text] [Related]
11. Vitamin A Supplementation for Prevention of Bronchopulmonary Dysplasia: Cornerstone of Care or Futile Therapy?
Gawronski CA; Gawronski KM
Ann Pharmacother; 2016 Aug; 50(8):680-4. PubMed ID: 27147702
[TBL] [Abstract][Full Text] [Related]
12. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
Bassler D
Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
[TBL] [Abstract][Full Text] [Related]
13. Low plasma retinol concentrations increase the risk of developing bronchopulmonary dysplasia and long-term respiratory disability in very-low-birth-weight infants.
Spears K; Cheney C; Zerzan J
Am J Clin Nutr; 2004 Dec; 80(6):1589-94. PubMed ID: 15585773
[TBL] [Abstract][Full Text] [Related]
14. Effect of Inhaled Nitric Oxide on Survival Without Bronchopulmonary Dysplasia in Preterm Infants: A Randomized Clinical Trial.
Hasan SU; Potenziano J; Konduri GG; Perez JA; Van Meurs KP; Walker MW; Yoder BA;
JAMA Pediatr; 2017 Nov; 171(11):1081-1089. PubMed ID: 28973344
[TBL] [Abstract][Full Text] [Related]
15. Enteral Vitamin A for Reducing Severity of Bronchopulmonary Dysplasia: A Randomized Trial.
Rakshasbhuvankar AA; Simmer K; Patole SK; Stoecklin B; Nathan EA; Clarke MW; Pillow JJ
Pediatrics; 2021 Jan; 147(1):. PubMed ID: 33386338
[TBL] [Abstract][Full Text] [Related]
16. Early inhaled nitric oxide in preterm infants <34 weeks with evolving bronchopulmonary dysplasia.
Jiang Q; Gao X; Liu C; Chen D; Lin X; Xia S; Zhuang D; Yang C; Zhu W; Liu L; Chen C; Sun B
J Perinatol; 2016 Oct; 36(10):883-9. PubMed ID: 27442155
[TBL] [Abstract][Full Text] [Related]
17. Effects of early inhaled nitric oxide therapy and vitamin A supplementation on the risk for bronchopulmonary dysplasia in premature newborns with respiratory failure.
Gadhia MM; Cutter GR; Abman SH; Kinsella JP
J Pediatr; 2014 Apr; 164(4):744-8. PubMed ID: 24388327
[TBL] [Abstract][Full Text] [Related]
18. Vitamin A supplementation in extremely low-birth-weight infants: subgroup analysis in small-for-gestational-age infants.
Londhe VA; Nolen TL; Das A; Higgins RD; Tyson JE; Oh W; Devaskar SU;
Am J Perinatol; 2013 Oct; 30(9):771-80. PubMed ID: 23329565
[TBL] [Abstract][Full Text] [Related]
19. Vitamin A supplementation to prevent mortality and short and long-term morbidity in very low birthweight infants.
Darlow BA; Graham PJ
Cochrane Database Syst Rev; 2007 Oct; (4):CD000501. PubMed ID: 17943744
[TBL] [Abstract][Full Text] [Related]
20. Inhaled nitric oxide for respiratory failure in preterm infants.
Barrington KJ; Finer NN
Cochrane Database Syst Rev; 2007 Jul; (3):CD000509. PubMed ID: 17636641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
